ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 689529 Null 0.00078227743523216 0.5481692
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.000837923650101952 0.31925453
NSC 699921 Null 0.000864214137711348 0.17055494
NSC 185049 Hydrazinecarbothioamide, 2-[[5-(1-oxopropoxy)-2-pyridinyl]methylene]- 0.000931492155975116 0.58222854
NSC 333054 Adriamycin, tetrahydropyranyl 0.000931492155975116 0.60157171
NSC 610456 Camptothecin Derivative 0.000931492155975116 0.8733329
NSC 665773 Null 0.000931492155975116 0.29986879
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.000931492155975116 0.74112394
NSC 676315 Null 0.000931492155975116 0.32278407
NSC 683555 Camptothecin Derivative 0.000931492155975116 0.78429088
Total:90  Current:6    [First] [Prev] [Next] [Last]